SUNPHARMA — Sun Pharmaceutical Industries Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Sun Pharmaceutical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	290,659	328,375	334,981	386,545	438,857
Cost of Revenue
Gross Profit	198,272	223,662	236,127	269,468	319,433
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	253,782	281,291	313,515	350,768	347,933
Operating Profit	36,877	47,084	21,466	35,777	90,924
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	38,102	50,096	27,994	44,813	94,084
Provision for Income Taxes
Net Income After Taxes	32,093	41,868	22,847	34,058	85,608
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	26,654	37,649	29,038	32,727	84,736
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	26,654	37,649	29,038	32,727	84,736
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.6	16.5	26.7	28	36
Dividends per Share